- Coping with flu-like symptoms and injection site reactions in the treatment subcutaneous interferon beta-1a od multiple sclerosis2014 | Faculty of Medicine in Pilsen
- SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients2022 | Second Faculty of Medicine
- A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer2012 | Third Faculty of Medicine
- Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma2023 | First Faculty of Medicine
- ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia2015 | First Faculty of Medicine
- Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO-The MIMOSA Study2013 | First Faculty of Medicine
- Efficacy and Safety of Anti-Interleukin-20 Monoclonal Antibody in Patients With Rheumatoid Arthritis A Randomized Phase IIa Trial2015 | First Faculty of Medicine
- Tolerability, treatment satisfaction and quality of life outcomes in stable multiple sclerosis patients switched from injectable therapies to auto injected intramuscular interferon beta 1a: The SFERA study2019 | Faculty of Medicine in Hradec Králové
- Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial2021 | Second Faculty of Medicine
- Multiple switches between GP2015, an etanercept biosimilar, with originator product do not impact efficacy, safety and immunogenicity in patients with chronic plaque-type psoriasis: 30-week results from the phase 3, confirmatory EGALITY study2018 | Third Faculty of Medicine
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease2017 | Second Faculty of Medicine
- Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial2019 | First Faculty of Medicine
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome2018 | Publication without faculty affiliation
- Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation A Randomized Clinical Trial2019 | First Faculty of Medicine
- Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trialPublication without faculty affiliation